Systemic Chemotherapy for Uterine Carcinoma: Metastatic and Adjuvant
- 10 July 2007
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (20), 2983-2990
- https://doi.org/10.1200/jco.2007.10.8431
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Phase II study of weekly docetaxel in patients with recurrent or metastatic endometrial cancer: AGO Uterus-4Gynecologic Oncology, 2007
- Management of endometrial cancerEuropean Journal of Surgical Oncology, 2006
- Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trialBritish Journal of Cancer, 2006
- Randomized Phase II Study of Two Doses of Gefitinib in Hormone-Refractory Prostate Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials GroupJournal of Clinical Oncology, 2005
- A New Addition to the Journal of Clinical Oncology: The Art of Oncology--When the Tumor Is Not the TargetJournal of Clinical Oncology, 2003
- Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomasInternational Journal of Gynecologic Cancer, 2002
- Extended Surgical Staging for Uterine Papillary Serous Carcinoma: Survival Outcome of Locoregional (Stage I–III) DiseaseGynecologic Oncology, 2001
- Treatment of Advanced or Recurrent Endometrial Carcinoma with Single-Agent CarboplatinGynecologic Oncology, 1993
- Epirubicin in advanced endometrial adenocarcinoma: a phase II study of the grupo ginecologico Español para el tratamiento oncologico (GGETO)European Journal of Cancer and Clinical Oncology, 1991
- A phase II study of cis-platinum for Recurrent corpus cancerEuropean Journal of Cancer (1965), 1980